1. Home
  2. NUTX vs PCRX Comparison

NUTX vs PCRX Comparison

Compare NUTX & PCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nutex Health Inc.

NUTX

Nutex Health Inc.

HOLD

Current Price

$201.86

Market Cap

1.3B

Sector

Technology

ML Signal

HOLD

Logo Pacira BioSciences Inc.

PCRX

Pacira BioSciences Inc.

HOLD

Current Price

$24.63

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NUTX
PCRX
Founded
2011
2006
Country
United States
United States
Employees
944
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.1B
IPO Year
2009
2010

Fundamental Metrics

Financial Performance
Metric
NUTX
PCRX
Price
$201.86
$24.63
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
4
Target Price
$252.50
$30.25
AVG Volume (30 Days)
121.6K
429.3K
Earning Date
04-30-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
7.93
107.44
EPS
15.87
0.19
Revenue
$875,257,000.00
$541,533,000.00
Revenue This Year
$6.12
$6.78
Revenue Next Year
$4.04
$8.54
P/E Ratio
$13.16
$130.00
Revenue Growth
82.36
26.04
52 Week Low
$83.99
$18.80
52 Week High
$224.28
$27.66

Technical Indicators

Market Signals
Indicator
NUTX
PCRX
Relative Strength Index (RSI) 57.10 49.49
Support Level $142.71 $24.61
Resistance Level $224.28 $25.17
Average True Range (ATR) 10.32 0.74
MACD -0.59 -0.10
Stochastic Oscillator 54.47 42.32

Price Performance

Historical Comparison
NUTX
PCRX

About NUTX Nutex Health Inc.

Nutex Health Inc is a physician-led, healthcare services and operations company with various hospital facilities in the U.S. states (hospital division), and a primary care-centric, risk-bearing population health management division. The company has three segments: the hospital division, the PHM division, and the real estate division. The hospital division implements and operates health care models, including micro-hospitals, specialty hospitals and hospital outpatient departments (HOPDs). The population health management (PHM) division owns and operates provider networks such as independent physician associations (IPAs). The Real Estate Entities own the land and hospital buildings which are leased to its hospital entities. The majority of the revenue is derived from the Hospital division.

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

Share on Social Networks: